Loading...
Neutralizing monoclonal antibodies for COVID-19 treatment and prevention
The SARS-CoV-2 pandemic has caused unprecedented global health and economic crises. Several vaccine approaches and repurposed drugs are currently under evaluation for safety and efficacy. However, none of them have been approved for COVID-19 yet. Meanwhile, several nMAbs targeting SARS-CoV-2 spike g...
Na minha lista:
| Udgivet i: | Biomed J |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Chang Gung University
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7685954/ https://ncbi.nlm.nih.gov/pubmed/33589377 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bj.2020.11.011 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|